Chembio Diagnostics Inc. (NASDAQ: CEMI) established initial surge of 60.23% at $5.64, as the Stock market unbolted on April 05, 2021. During the day, the stock rose to $6.25 and sunk to $5.02 before settling in for the price of $3.52 at the close. Taking a more long-term approach, CEMI posted a 52-week range of $3.01-$15.89.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 6.00%. Meanwhile, its Annual Earning per share during the time was -40.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -65.80%. This publicly-traded company’s shares outstanding now amounts to $20.16 million, simultaneously with a float of $17.38 million. The organization now has a market capitalization sitting at $113.42 million. At the time of writing, stock’s 50-day Moving Average stood at $5.54, while the 200-day Moving Average is $5.07.
If we measure the efficiency of the company that is accounted for 355 employees. It has generated 91,465 per worker during the last fiscal year. Meanwhile, its income per employee was -71,891. The stock had 9.23 Receivables turnover and 0.42 Total Asset turnover. For the Profitability, stocks gross margin was +26.47, operating margin was -67.60 and Pretax Margin of -80.01.
Chembio Diagnostics Inc. (CEMI) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Chembio Diagnostics Inc. industry. Chembio Diagnostics Inc.’s current insider ownership accounts for 0.50%, in contrast to 47.90% institutional ownership.
Chembio Diagnostics Inc. (CEMI) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 12/30/2020, it has been observed that the corporation posted -$0.35 earnings per share (EPS) during the time that was less the consensus figure (set at -$0.28) by -$0.07. This company achieved a net margin of -78.60 while generating a return on equity of -98.52. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
Chembio Diagnostics Inc.’s EPS decrease for this current 12-month fiscal period is -65.80% and is forecasted to reach -0.94 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 25.00% through the next 5 years, which can be compared against the -40.00% growth it accomplished over the previous five years trading on the market.
Chembio Diagnostics Inc. (NASDAQ: CEMI) Trading Performance Indicators
Let’s observe the current performance indicators for Chembio Diagnostics Inc. (CEMI). It’s Quick Ratio in the last reported quarter now stands at 2.20. The Stock has managed to achieve an average true range (ATR) of 0.54. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.49.
In the same vein, CEMI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.34, a figure that is expected to reach -0.32 in the next quarter, and analysts are predicting that it will be -0.94 at the market close of one year from today.
Technical Analysis of Chembio Diagnostics Inc. (CEMI)
Now, what If we examine the latest scores posted by [Chembio Diagnostics Inc., CEMI]. During the last 5-days, its volume was better the volume of 5.19 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 39.43% While, its Average True Range was 0.60.
Raw Stochastic average of Chembio Diagnostics Inc. (CEMI) in the period of the previous 100 days is set at 42.62%, which indicates a major fall in contrast to 79.11% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 208.87% that was higher than 116.67% volatility it exhibited in the past 100-days period.